Patricia Ann Basford

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignees: Pfizer Corporation, Agouron Pharmaceuticals, Inc.. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patricia Ann Basford. Retrieved from https://idiyas.com/inventor/patricia-ann-basford

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 87.5

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 22(Granted Patents)

Company Filing History:

Agouron Pharmaceuticals, Inc.

patents

Years Active: 2004-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10278974 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (2019-05-07),

2. 9861638 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (2018-01-09),

3. 9045487 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (2015-06-02),

4. 8754072 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one (2014-06-17),

5. 7579471 - Tropane derivatives useful in therapy (2009-08-25),

6. 7217721 - Tropane derivatives useful in therapy (2007-05-15),

7. 6855724 - Tropane derivatives useful in therapy (2005-02-15),

8. 6683085 - Salt form and polymorphs (2004-01-27),

Title: The Innovative Journey of Patricia Ann Basford

Introduction

Patricia Ann Basford, an esteemed inventor based in Sandwich, GB, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio consisting of eight patents, her work exemplifies dedication and innovation, particularly in the creation of polymorphic forms of vital pharmaceutical compounds.

Latest Patents

Among her latest innovations, Basford has developed novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one. These polymorphic forms have potential applications as components of pharmaceutical compositions for treating mammalian diseases mediated by poly(ADP-ribose) polymerase activity, including cancer. This invention represents a significant advancement in therapeutic options and highlights her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Basford has collaborated with leading pharmaceutical companies, most notably Pfizer Corporation and Agouron Pharmaceuticals, Inc. Her extensive experience in research and development has been instrumental in driving innovation within these organizations and advancing the field of medication development.

Collaborations

Patricia Ann Basford has worked alongside remarkable colleagues, including Anthony Michael Campeta and Adam Gillmore. These collaborations have not only enhanced her research endeavors but have also contributed to the wider scientific community's understanding of pharmaceutical compounds.

Conclusion

Patricia Ann Basford's contributions to the field of pharmaceuticals through her patents and collaborations are commendable. Her innovative spirit and dedication to improving healthcare outcomes through her inventions make her a significant figure in the world of inventors. As she continues to push the boundaries of research, the impact of her work will surely resonate in the fight against critical diseases.

Profile summary based on public USPTO records.